NVAX – Novavax, Inc.
Novavax, Inc.NVAX
$7.42Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,201,007,488.00
EPSttm : 2.75
Novavax, Inc.
$7.42
6.08%$0.425Float Short %
31.48
Margin Of Safety %
Put/Call OI Ratio
0.68
EPS Next Q Diff
-3.17
EPS Last/This Y
3.79
EPS This/Next Y
-2.24
Price
6.99
Target Price
15.29
Analyst Recom
2.14
Performance Q
-11.18
Relative Volume
0.66
Beta
2.77
Ticker: NVAX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-07 | NVAX | 5.94 | 0.85 | 0.51 | 283413 |
| 2025-05-08 | NVAX | 6.64 | 0.84 | 0.14 | 286992 |
| 2025-05-09 | NVAX | 5.97 | 0.74 | 0.33 | 311746 |
| 2025-05-12 | NVAX | 6.34 | 0.74 | 0.19 | 301219 |
| 2025-05-13 | NVAX | 6.18 | 0.72 | 0.21 | 306529 |
| 2025-05-14 | NVAX | 5.95 | 0.72 | 0.19 | 309050 |
| 2025-05-15 | NVAX | 6.3 | 0.71 | 0.07 | 313794 |
| 2025-05-16 | NVAX | 6.73 | 0.71 | 0.30 | 314166 |
| 2025-05-19 | NVAX | 7.73 | 0.68 | 0.37 | 288341 |
| 2025-05-20 | NVAX | 7.68 | 0.67 | 0.43 | 362471 |
| 2025-05-21 | NVAX | 7.12 | 0.68 | 0.31 | 382865 |
| 2025-05-22 | NVAX | 7.26 | 0.66 | 0.15 | 389833 |
| 2025-05-23 | NVAX | 7.25 | 0.63 | 0.07 | 405220 |
| 2025-05-27 | NVAX | 7.38 | 0.66 | 0.15 | 368234 |
| 2025-05-28 | NVAX | 6.93 | 0.65 | 0.38 | 373700 |
| 2025-05-29 | NVAX | 7.18 | 0.65 | 0.22 | 382690 |
| 2025-05-30 | NVAX | 7.33 | 0.64 | 0.16 | 386925 |
| 2025-06-02 | NVAX | 7.05 | 0.68 | 0.40 | 360666 |
| 2025-06-03 | NVAX | 7.26 | 0.68 | 0.13 | 367257 |
| 2025-06-04 | NVAX | 7.14 | 0.68 | 0.16 | 369488 |
| 2025-06-05 | NVAX | 6.99 | 0.68 | 0.32 | 374412 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-07 | NVAX | 5.95 | 234.0 | - | 0.49 |
| 2025-05-08 | NVAX | 6.65 | 234.0 | - | 0.49 |
| 2025-05-09 | NVAX | 5.97 | -102.0 | - | 0.45 |
| 2025-05-12 | NVAX | 6.34 | -102.0 | - | 0.45 |
| 2025-05-13 | NVAX | 6.19 | -84.8 | - | 0.45 |
| 2025-05-14 | NVAX | 5.95 | -110.1 | - | 0.45 |
| 2025-05-15 | NVAX | 6.30 | -110.1 | - | 0.45 |
| 2025-05-16 | NVAX | 6.73 | -110.1 | - | 2.40 |
| 2025-05-19 | NVAX | 7.74 | -110.1 | - | 2.40 |
| 2025-05-20 | NVAX | 7.68 | -110.1 | - | 2.40 |
| 2025-05-21 | NVAX | 7.12 | -124.2 | - | 2.40 |
| 2025-05-22 | NVAX | 7.29 | -124.2 | - | 2.40 |
| 2025-05-23 | NVAX | 7.25 | -124.2 | - | 2.40 |
| 2025-05-27 | NVAX | 7.38 | -124.2 | - | 2.56 |
| 2025-05-28 | NVAX | 6.92 | -124.2 | - | 2.56 |
| 2025-05-29 | NVAX | 7.18 | -124.2 | - | 2.56 |
| 2025-05-30 | NVAX | 7.34 | -124.2 | - | 2.56 |
| 2025-06-02 | NVAX | 7.07 | -124.2 | - | 2.56 |
| 2025-06-03 | NVAX | 7.26 | -124.2 | - | 2.56 |
| 2025-06-04 | NVAX | 7.14 | -124.2 | - | 2.56 |
| 2025-06-05 | NVAX | 6.99 | -124.2 | - | 2.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-07 | NVAX | -0.10 | 1.13 | 27.80 |
| 2025-05-08 | NVAX | -0.10 | 1.13 | 27.80 |
| 2025-05-09 | NVAX | -0.10 | 1.13 | 27.80 |
| 2025-05-12 | NVAX | -0.10 | -0.65 | 28.68 |
| 2025-05-13 | NVAX | -0.10 | -0.65 | 28.68 |
| 2025-05-14 | NVAX | -0.10 | -0.65 | 28.68 |
| 2025-05-15 | NVAX | -0.10 | -0.65 | 28.68 |
| 2025-05-16 | NVAX | -0.10 | -0.65 | 28.68 |
| 2025-05-19 | NVAX | -0.10 | -1.51 | 28.68 |
| 2025-05-20 | NVAX | -0.10 | -1.51 | 28.68 |
| 2025-05-21 | NVAX | -0.10 | -1.51 | 28.68 |
| 2025-05-22 | NVAX | -0.10 | -1.51 | 28.68 |
| 2025-05-23 | NVAX | -0.10 | -1.51 | 28.68 |
| 2025-05-27 | NVAX | -0.10 | -5.37 | 28.68 |
| 2025-05-28 | NVAX | -0.10 | -5.37 | 31.48 |
| 2025-05-29 | NVAX | -0.10 | -5.37 | 31.48 |
| 2025-05-30 | NVAX | -0.10 | -5.37 | 31.48 |
| 2025-06-02 | NVAX | -0.10 | -4.87 | 31.48 |
| 2025-06-03 | NVAX | -0.10 | -4.87 | 31.48 |
| 2025-06-04 | NVAX | -0.10 | -4.87 | 31.48 |
| 2025-06-05 | NVAX | -0.10 | -4.87 | 31.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.93
Avg. EPS Est. Current Quarter
-0.05
Avg. EPS Est. Next Quarter
-0.24
Insider Transactions
-0.1
Institutional Transactions
-4.87
Beta
2.77
Average Sales Estimate Current Quarter
134
Average Sales Estimate Next Quarter
118
Fair Value
Quality Score
96
Growth Score
35
Sentiment Score
37
Actual DrawDown %
97.9
Max Drawdown 5-Year %
-98.8
Target Price
15.29
P/E
2.64
Forward P/E
19.62
PEG
0.04
P/S
0.9
P/B
P/Free Cash Flow
EPS
2.65
Average EPS Est. Cur. Y
2.56
EPS Next Y. (Est.)
0.31
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
38.14
Relative Volume
0.66
Return on Equity vs Sector %
-656.8
Return on Equity vs Industry %
-639
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
2.06
EBIT Estimation
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 952
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading